ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1107

$1.15M Total Retail Price of All Prescriptions

Rank: 66 out of 1107

511 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

29% of this provider’s 511 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 11,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 813 630 1 3
HYDROCODONE-ACETAMINOPHEN 708 340 S3 2 1
FUROSEMIDE 534 392 3 7
OMEPRAZOLE 508 320 4 4
LISINOPRIL 470 327 5 2
AMLODIPINE BESYLATE 442 372 6 6
SIMVASTATIN 408 259 7 5
NEXIUM 350 192 8 18
CRESTOR 331 162 9 23
METFORMIN HCL 292 146 10 8
WARFARIN SODIUM 288 231 11 15
RANITIDINE HCL 246 215 12 21
HYDROCHLOROTHIAZIDE 243 150 13 11
ATORVASTATIN CALCIUM 242 191 14 13
TRILIPIX 237 111 15 153
METOPROLOL TARTRATE 226 176 16 10
POTASSIUM CHLORIDE 220 170 17 14
GLIPIZIDE ER 216 126 18 115
GLIPIZIDE XL 208 161 19 166
TRAMADOL HCL 206 96 20 26
CLOPIDOGREL 200 170 21 28
CARVEDILOL 194 136 22 27
ZOLPIDEM TARTRATE 193 110 23 22
SPIRIVA 157 68 24 57
METOPROLOL SUCCINATE 157 128 24 16
ACETAMINOPHEN-CODEINE 146 62 S3 26 120
CITALOPRAM HBR 143 110 27 17
PLAVIX 137 115 28 39
LYRICA 134 34 29 83
JANUVIA 134 56 29 60
PROAIR HFA 133 42 31 37
LOVAZA 132 64 32 101
SERTRALINE HCL 126 75 33 20
DIOVAN 125 75 34 51
PRAVASTATIN SODIUM 123 96 35 12
ZETIA 122 57 36 76
AZITHROMYCIN 122 74 36 35
CEFDINIR 122 89 36 163
GABAPENTIN 120 78 39 9
POLYETHYLENE GLYCOL 3350 119 71 40 46
NIASPAN 114 41 41 125
CIPROFLOXACIN HCL 111 83 42 59
DIGOXIN 111 94 42 52
ATENOLOL 104 82 44 19
MELOXICAM 99 58 45 25
TAMSULOSIN HCL 99 77 45 30
FLUOXETINE HCL 98 27 47 47
DOXYCYCLINE HYCLATE 93 59 48 128
FENOFIBRATE 89 49 49 67
BYSTOLIC 88 46 50 138
TRICOR 86 65 51 95
PANTOPRAZOLE SODIUM 86 68 51 30
SYMBICORT 86 38 51 124
IBUPROFEN 85 24 54 63
AMOX TR-POTASSIUM CLAVULANATE 85 42 54 131
LOSARTAN POTASSIUM 83 54 56 29
AMLODIPINE BESYLATE-BENAZEPRIL 80 55 57 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 36 58 24
INSULIN SYRINGE 79 33 58 78
LEVEMIR 79 37 58 191
TRAZODONE HCL 77 50 61 33
CLONIDINE HCL 72 51 62 53
DILTIAZEM 24HR ER 72 51 62 172
DIOVAN HCT 71 17 64 106
FLUCONAZOLE 69 38 65 150
LEVOCETIRIZINE DIHYDROCHLORIDE 69 53 65 203
DEXILANT 67 35 67 212
PAROXETINE HCL 66 35 68 45
FLUTICASONE PROPIONATE 66 44 68 38
NOVOLOG MIX 70-30 65 26 70 264
PROPRANOLOL HCL 63 38 71 134
PROMETHAZINE HCL 61 19 R 72 44
SUCRALFATE 61 27 72 121
DONEPEZIL HCL 61 61 72 32
LIPITOR 60 19 75 109
LEVOFLOXACIN 59 35 76 71
ALLOPURINOL 59 46 76 36
ISOSORBIDE MONONITRATE ER 58 48 78 34
PRADAXA 58 37 78 241
SPIRONOLACTONE 56 49 80 72
AMITRIPTYLINE HCL 56 52 R 80 48
SINGULAIR 55 35 82 65
ENALAPRIL MALEATE 55 55 82 98
DICLOFENAC SODIUM 54 37 84 74
KLOR-CON M20 53 44 85 75
CYCLOBENZAPRINE HCL 53 14 R 85 56
JANUMET 52 37 87 197
METFORMIN HCL ER 50 21 88 58
DILTIAZEM 24HR CD 50 39 88 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.